The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects
Open accessAbstract
Background & aims Irritable bowel syndrome (IBS) is a significant gastrointestinal disorder with unknown etiology. The symptoms can greatly weaken patients' quality of life and account for notable economical costs for society. Contribution of the gastrointestinal microbiota in IBS has been suggested. Our objective was to characterize putative differences in gastrointestinal microbiota between patients with IBS and control subjects. These differences could potentially have a causal relationship with the syndrome.Methods Microbial genomes from fecal samples of 24 patients with IBS and 23 controls were collected, pooled in a groupwise manner, and fractionated according to their guanine cytosine content. Selected fractions were analyzed by extensive high-throughput 16S ribosomal RNA gene cloning and sequencing of 3753 clones. Some of the revealed phylogenetic differences were further confirmed by quantitative polymerase chain reaction assays on individual samples.Results The coverage of the clone libraries of IBS subtypes and control subjects differed significantly (P < .0253). The samples were also distinguishable by the Bayesian analysis of bacterial population structure. Moreover, significant (P < .05) differences between the clone libraries were found in several bacterial genera, which could be verified by quantitative polymerase chain reaction assays of phylotypes belonging to the genera Coprococcus, Collinsella, and Coprobacillus.Conclusions The study showed that fecal microbiota is significantly altered in IBS. Further studies on molecular mechanisms underlying these alterations are needed to elucidate the exact role of intestinal bacteria in IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“others have shown that the colonic microbiome is altered in patients with IBS, when compared with healthy controls. 15 - 18”
From Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis (2023) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The faecal microbiome of patients with IBS may differ significantly from that of healthy individuals.216”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [216]
In the citing paper
“The consortium and dose used in this study had previously proved effective in both prevention of Clostridium difficile in vivo 8,9 and the modulation of the composition of the intestinal re-growth population following antibiotic therapy.10,11”
In the citing paper
“Kassinen et al. 8 have shown that both the lactobacillus and the bifidobacterial components of the microbiota of IBS sufferers were present in lower numbers than in the controls suggesting a value for intervention strategies comprising both organisms.”
In the citing paper
“Imbalanced microbiota may be one such factor, as deviations in microbiota have been seen in IBS 23-25 and as studies on inflammatory bowel disease imply that the microbiota is able to trigger mucosal inflammation. 26”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [25]
In the citing paper
“A stabilization of the microbiota composition may be particularly important in IBS, as no single deviance has been identified in IBS microbiota, but various alterations in the bacterial composition have been characterized. 23-25, 35”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [25]
In the citing paper
“Recent studies using these advanced molecular biology techniques have demonstrated quantitative alterations of specific bacterial groups (33, 34, 81, 85, 142, 154) and reduced diversity in gut microbial populations in patients with IBS compared with healthy controls (33, 40).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [85]
In the citing paper
“Elevations in the Firmicutes:Bacteroidetes ratio have been associated with a high-fat diet and obesity[274,328,329], irritable bowel syndrome[330], hypertension[331], type 1 diabetes[276], and HIV[332].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [330]
In the citing paper
“A departure from the physiological balance of the enteric microbiota has been suggested as a factor in the pathophysiology of IBS, a condition in which abnormal gastrointestinal motility and secretion is implicated as a cause of alterations in bowel habits.79”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [79]
In the citing paper
“A departure from the physiological balance of the enteric microbiota has been suggested as a factor in the pathophysiology of IBS, a condition in which abnormal gastrointestinal motility and secretion is implicated as a cause of alterations in bowel habits.79”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
ARB: a software environment for sequence data
Ludwig, W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh293 · Cited by 6,714
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Multiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,905
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
THE POPULATION FREQUENCIES OF SPECIES AND THE ESTIMATION OF POPULATION PARAMETERS
Good, I. J. (1953) · Biometrika · doi:10.1093/biomet/40.3-4.237 · Cited by 3,427
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,001
Gresse, R., Chaucheyras‐Durand, F., Garrido, J. J., Denis, S., Jiménez-Marín, Á., Beaumont, M., de Wiele, T. V., Forano, É., & Blanquet‐Diot, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.703421 · Cited by 19
Carter, D., Beer-Gabel, M., Tzur, D., Levy, G., Derazne, E., Novis, B., & Afek, A. B. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000114 · Cited by 19
The Noncolonic Microbiome: Does it Really Matter?
Lawson, R. D., & Coyle, W. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0111-6 · Cited by 19
Focus on irritable bowel syndrome.
Scalera, A., & Loguercio, C. (2012) · PubMed · Cited by 19
Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?
Cremon, C., Carini, G., GIORGIO, R. D., Stanghellini, V., Corinaldesi, R., & Barbara, G. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.33 · Cited by 19
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance
Taschler, U., Hasenoehrl, C., Storr, M., & Schicho, R. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_105 · Cited by 20
The Future of Probiotics for Disorders of the Brain-Gut Axis
Quigley, E. M. M., & Shanahan, F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_19 · Cited by 18
RETRACTED ARTICLE: Gut microbiota and related diseases: clinical features
Stanghellini, V., Barbara, G., Cremon, C., Cogliandro, R. F., Antonucci, A., Gabusi, V., Frisoni, C., GIORGIO, R. D., Grasso, V., Serra, M., et al. (2010) · Internal and Emergency Medicine · doi:10.1007/s11739-010-0451-0 · Cited by 18
RetractedRifaximin for the treatment of irritable bowel syndrome
Cremonini, F., & Lembo, A. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.651458 · Cited by 18
Zhang, Y., Feei, Z., Zhang, H., Pan, B., Li, Y., Majid, H. A., & Lee, Y. Y. (2018) · JGH Open · doi:10.1002/jgh3.12125 · Cited by 18
Functional Gastrointestinal Disorders.
Duffy, M., Boggiano, V. L., Ganesh, R., & Mueller, M. (2023) · Primary Care · doi:10.1016/j.pop.2023.03.006 · Cited by 13
Recent advances in the diagnosis of irritable bowel syndrome
El‐Salhy, M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1067138 · Cited by 18
The Mexican consensus on irritable bowel syndrome
Carmona-Sánchez, R., Icaza-Chávez, M. E., Bielsa-Fernández, M. V., Gomez-Escudero, O., Bosques‐Padilla, F., Coss‐Adame, E., Esquivel-Ayanegui, F., Flores-Rendón, Á. R., González-Martínez, M. A., Huerta-Iga, F. M., et al. (2016) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2016.01.004 · Cited by 19
Ko, S., Kim, J., Han, G., Kim, S., Kim, H., Yeo, I., Ryu, B., & Park, J.-W. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.3054 · Cited by 18
Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders
Sanger, G. J., Chang, L., Bountra, C., & Houghton, L. A. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10369922 · Cited by 17
Mokhtar, N. M., Jaafar, N., Alfian, E., Rathi, N. D. M., Rani, R. A., & Ali, R. A. R. (2021) · Acta gastro-enterologica belgica · doi:10.51821/84.4.009 · Cited by 17
Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome
Barbara, G., & Cremon, C. (2008) · Gut · doi:10.1136/gut.2008.150821 · Cited by 17
Rifaximin in the Treatment of Irritable Bowel Syndrome
Farrell, D. J. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31827559a3 · Cited by 17
Review: Do patients with functional gastrointestinal disorders have an altered gut flora?
Quigley, E. M. M. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09335636 · Cited by 17
Bloating and Abdominal Distention: Not So Poorly Understood Anymore!
Simrén, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.023 · Cited by 17
Ko, S., Ryu, B., Kim, J., Hong, B.-G., Yeo, I., Lee, B., Lee, J., & Park, J.-W. (2011) · Trials · doi:10.1186/1745-6215-12-219 · Cited by 17
Andresen, V., Pehl, C., Allescher, H. ‐., Bischoff, S. C., Enck, P., Frieling, T., Haag, S., Holtmann, G., Karaus, M., Keller, J., et al. (2011) · Cited by 17
Chang, C. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s167031 · Cited by 17
The role of gut microbiota in the treatment of irritable bowel syndrome
Leylabadlo, H. E., Heravi, F. S., Soltani, E., Abbasi, A., Kafil, H. S., Parsaei, M., Sanaie, S., Ahmadian, Z., & Ghotaslou, R. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000284 · Cited by 16
Quan, R., Decraecker, L., Appeltans, I., Cuende‐Estévez, M., Remoortel, S. V., Aguilera‐Lizarraga, J., Wang, Z., Hicks, G. A., Wykosky, J., McLean, P. G., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003042 · Cited by 16
Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
Wang, Y., Zheng, F., Liu, S., & Luo, H. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/9759138 · Cited by 16
Peppermint oil effects on the gut microbiome in children with functional abdominal pain
Thapa, S., Luna, R. A., Chumpitazi, B. P., Oezguen, N., Abdel‐Rahman, S. M., Garg, U. C., Musaad, S. M. A., Versalovic, J. A., Kearns, G. L., & Shulman, R. J. (2022) · Clinical and Translational Science · doi:10.1111/cts.13224 · Cited by 15
Microbiome Analysis in the Esophagus
Suerbaum, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.017 · Cited by 16
Liu, C., Zhang, C., Lv, W., Chao, L., Li, Z., Shi, D., & Guo, S. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8358151 · Cited by 16
The Efficacy of Probiotics in IBS
Quigley, E. M. M. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31816244ca · Cited by 16
Association between Helicobacter pylori infection and irritable bowel syndrome
Li, C., Shuai, Y., Zhou, X., & Chen, H. (2020) · Medicine · doi:10.1097/md.0000000000022975 · Cited by 15
Sommermeyer, H., Chmielowiec, K., Bernatek, M., Olszewski, P., Kopczyński, J., & Piątek, J. (2024) · Nutrients · doi:10.3390/nu16101503 · Cited by 16
The Role of the TRPV4 Channel in Intestinal Physiology and Pathology
Liu, D., Mao, M., Liu, W., Xie, L., Zhong, X., Cao, W., & Chen, L. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s483350 · Cited by 17
Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome.
Ghorbani, S., Nejad, A., Law, D., Chua, K. S., Amichai, M. M., & Pimentel, M. (2015) · PubMed Central · Cited by 15
Xiong, F., Xiong, M., Ma, Z., Huang, S., Li, A., & Liu, S. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/3059201 · Cited by 15
Rijnaarts, I., Witteman, B. J. M., Zoetendal, E. G., Govers, C., de Wit, N. J. W., & de Roos, N. M. (2021) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2021.01.007 · Cited by 16
Wan, C., Kong, X., Liao, Y., Chen, Q., Chen, M., Ding, Q., Liu, X., Zhong, W., Xu, C., Liu, W., et al. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00971-5 · Cited by 15
Gut Microbiota, Obesity and Diabetes
Bibiloni, R., Membrez, M., & Chou, C. J. (2009) · Annales Nestlé (English ed ) · doi:10.1159/000187168 · Cited by 15
Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
Goepp, J. G., Fowler, E., Mcbride, T., & Landis, D. L. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2013.099 · Cited by 15
Targeted therapies for diarrhea-predominant irritable bowel syndrome
Olden, K. W. (2012) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s29023 · Cited by 15
The impact of dietary fibres on the physiological processes of the large intestine
Gill, S., Chater, P. I., Wilcox, M. D., Pearson, J. P., & Brownlee, I. A. (2018) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2018.06.001 · Cited by 15
FMT: First Step in a Long Journey
Brandt, L. J. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.165 · Cited by 15
Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome
Li, X., Li, X., Xiao, H., Xu, J., He, J., Xiao, C., Zhang, B., Cao, M., & Hong, W. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1492349 · Cited by 15
Schmitz, L., Ferrari, N., Schwiertz, A., Rusch, K., Woestmann, U., Mahabir, E., & Gräf, C. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0459-9 · Cited by 15
Mazzawi, T. R. E., Hausken, T., & El‐Salhy, M. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2036809 · Cited by 16
Irritable Bowel Syndrome: A Practical Approach
Clark, C., & DeLegge, M. H. (2008) · Nutrition in Clinical Practice · doi:10.1177/0884533608318107 · Cited by 14
Osipov, G. A., Boĭko, N. B., Федосова, Н. Ф., Kasikhina, S. A., & Lyadov, K. V. (2009) · Microbial Ecology in Health and Disease · doi:10.3109/08910600903462657 · Cited by 15
What is the evidence for the use of probiotics in functional disorders?
Quigley, E. M. M. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0072-1 · Cited by 14
Health benefits of probiotics for the elderly: a review
Baker, H. C., Tran, D. N., & Thomas, L. V. (2009) · Journal of Foodservice · doi:10.1111/j.1748-0159.2009.00147.x · Cited by 15
Shrinkage of the Human Core Microbiome and a Proposal for Launching Microbiome Biobanks
Barzegari, A., Saeedi, N., & Saei, A. A. (2014) · Future Microbiology · doi:10.2217/fmb.14.22 · Cited by 14
Almansa, C., Agrawal, A. K., & Houghton, L. A. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.9 · Cited by 14
Forensic human identification using skin microbiome genetic signatures
Schmedes, S. E., Woerner, A. E., & Budowle, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815379-6.00011-8 · Cited by 13
Xie, Q., Liu, C., Fu, W., Chen, C., Gu, S., Luo, D., & Xue, W. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112840 · Cited by 13
VISUALIZATION AND STATISTICAL COMPARISONS OF MICROBIAL COMMUNITIES USING PACKAGES ON PHYLOCHIP DATA
Holmes, S., Alekseyenko, A. V., TIMME, A., Nelson, T. A., Pasricha, P. J., & Spormann, A. M. (2010) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814335058_0016 · Cited by 13
Abdominal Bloating and Distension: What Is the Role of the Microbiota
Issa, B., Wafaei, N. A., & Whorwell, P. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1834-4 · Cited by 13
Shariatpanahi, Z. V., Jamshidi, F., Nasrollahzadeh, J., Amiri, Z., & Teymourian, H. (2018) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.62889 · Cited by 13
Relationship between defecation status and blood pressure level or blood pressure variability
Kubozono, T., Akasaki, Y., Kawasoe, S., Ojima, S., Yamaguchi, S., Kuwahata, S., Takenaka, T., Maeda, M., Fujiwara, S., Ikeda, Y., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01435-3 · Cited by 13
Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome
Kasir, R., Zakko, S. F., Zakko, P., Adler, M., Lee, A., Dhingra, S., & Guttermuth, C. F. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3872-9 · Cited by 13
Casado‐Bedmar, M., de‐Faria, F. M., Biskou, O., Lindqvist, C. M., Ranasinghe, P. D., Bednarska, O., Peterson, C., Walter, S. A., Carlson, M., & Keita, Å. V. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.4a0521-228r · Cited by 13
EFECTOS CLÍNICOS DE LOS PROBIÓTICOS: QUÉ DICE LA EVIDENCIA
Claudia Manzano, A., Diana Estupiñán, G., & Poveda, E. (2012) · Revista chilena de nutrición · doi:10.4067/s0717-75182012000100010 · Cited by 13
Lee, J. Y., Rheem, S., Yun, B., Ahn, Y.-J., Joung, J. Y., Lee, S. J., Oh, S., Chun, T., Rheem, I., Yea, H. S., et al. (2013) · International Journal of Dairy Technology · doi:10.1111/1471-0307.12028 · Cited by 13
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Katzka, D. A. (2008) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)79137-2 · Cited by 13
Ramos, G. P., & Camilleri, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07700-8 · Cited by 14
Mao, M., Zhou, Y., Jiao, Y., Yin, S., Cheung, C., Yu, W., Gao, P., & Yang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.975376 · Cited by 14
Huang, L.-S., Yeh, Y., Chiu, S.-F., Huang, P.-J., Chu, L. J., Huang, C.-Y., Cheng, F.-W., Chen, L., Lin, H., Shih, Y.-W., et al. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100661 · Cited by 12
Umeano, L., Iftikhar, S., Alhaddad, S. F., Paulsingh, C. N., Riaz, M. F., Garg, G., & Mohammed, L. (2024) · Cureus · doi:10.7759/cureus.58306 · Cited by 13
Mazzawi, T. R. E., El‐Salhy, M., Lied, G. A., & Hausken, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.524851 · Cited by 15
Probiotics and Irritable Bowel Syndrome
Korpela, R., & Niittynen, L. (2012) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v23i0.18573 · Cited by 13
Valeur, J., Valeur, J., Morken, Norin, E. L., Midtvedt, & Berstad (2010) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s11349 · Cited by 12
Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis.
Azami, M., Badfar, G., Abangah, G., & Mahmoudi, L. (2019) · Gastroenterology and hepatology from bed to bench. · Cited by 12
Rifaximin Therapy of Irritable Bowel Syndrome
Koo, H. L., Sabounchi, S., Huang, D. B., & DuPont, H. L. (2012) · Clinical Medicine Insights Gastroenterology · doi:10.4137/cgast.s7382 · Cited by 12
Environmental Factors and Their Impact on the Intestinal Microbiota: A Role for Human Disease?
Biedermann, L., & Rogler, G. (2012) · Digestive Diseases · doi:10.1159/000342590 · Cited by 12
The gut microbiota and disease – an inner repository for drug discovery
Shanahan, F., & Kiely, B. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.02.006 · Cited by 12
Hagerty, S. L., Ellingson, J. M., Helmuth, T. B., Bidwell, L. C., Hutchison, K. E., & Bryan, A. D. (2019) · Perspectives on Psychological Science · doi:10.1177/1745691619827010 · Cited by 12
Zhang, Y., Wang, S., Wang, H., Cao, M., Wang, M., Zhang, B., Xiao, C., Zhu, H., & Du, S. (2024) · Digestion · doi:10.1159/000540420 · Cited by 11
Zeraattalab-Motlagh, S., Ranjbar, M., Mohammadi, H., & Adibi, P. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae107 · Cited by 11
Sood, R., Gracie, D. J., Gold, M. J., To, N., Pinto-Sánchez, M. I., Berčík, P., Moayyedi, P., Ford, A. C., & Law, G. R. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13949 · Cited by 11
Clinical Relevance of Gastrointestinal Microbiota During Pregnancy: A Primer for Nurses
Chung, S.-Y., Ravel, J., & Regan, M. B. (2017) · Biological Research For Nursing · doi:10.1177/1099800417732412 · Cited by 13
Fecal microbiota transplantation for patients with irritable bowel syndrome
Wen, W., Zhang, H., Shen, J., Wei, L., & Shen, S. (2018) · Medicine · doi:10.1097/md.0000000000012661 · Cited by 11
Influence of Gut Microbiota on Behavior and Its Disturbances
Ignatova, V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85317 · Cited by 13
Neurophysiologic Mechanisms of Human Large Intestinal Motility ☆
Bharucha, A. E., & Brookes, S. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00023-2 · Cited by 12
Xia, X., Xie, Y., Chen, Q., Ding, D., Wang, Z., Xu, Y., Wang, Y., Wang, X., & Ding, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1053103 · Cited by 11
Fond, G. B., Chevalier, G., Eberl, G., & Leboyer, M. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.10.016 · Cited by 14
Probiotics and Health Claims: Challenges for Tailoring their Efficacy
Chassard, C., Grattepanche, F., & Lacroix, C. (2010) · Wiley eBooks · doi:10.1002/9781444329384.ch4 · Cited by 11
Shetty, S. A. (2019) · doi:10.18174/468013 · Cited by 11
Yang, Y., Kumrungsee, T., Katô, N., Fukuda, S., Kuroda, M., & Yamaguchi, S. (2021) · Fermentation · doi:10.3390/fermentation7040294 · Cited by 11
Wang, D., Russel, W. A., Sun, Y., Belanger, K. D., & Ay, A. A. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.12.015 · Cited by 11
The role of the gut microbiome in paediatric irritable bowel syndrome
McHarg, A. S., & Leach, S. T. (2022) · AIMS Microbiology · doi:10.3934/microbiol.2022030 · Cited by 11
Dual beta-lactam treatment: Pros and cons
Guerra, D., Vidal, P., Paccoud, O., Maillard, A., Cachera, L., Junot, H., Gauzit, R., Zahar, J., Abreu, M. A., & Bleibtreu, A. (2022) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000189 · Cited by 10
Widjaja, F., & Rietjens, I. M. C. M. (2023) · Biomedicines · doi:10.3390/biomedicines11102658 · Cited by 12
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis
Cremon, C., Pallotti, F., Bacchilega, M., Stanghellini, V., Corinaldesi, R., & Barbara, G. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.6.735 · Cited by 10
Free fecal water in the horse – an unsolved problem
Ertelt, A., & Gehlen, H. (2015) · Pferdeheilkunde Equine Medicine · doi:10.21836/pem20150308 · Cited by 10
Characterization of the fecal microbiota differs between age groups in Koreans
Kook, S. Y., Kim, Y.-J., Kang, B., Choe, Y. H., Kim, Y., & Kim, S. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.2.246 · Cited by 10
Sometti, D., Ballan, C., Wang, H., Braun, C., & Enck, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-83994-4 · Cited by 11
Oliver, L., Ramió‐Pujol, S., Amoedo, J., Malagón, M., Serrano, M., Bahí, A., Lluansí, A., Torrealba, L., Busquets, D., Pardo, L., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.639948 · Cited by 11
Stott, K. J., Phillips, B., Parry, L., & May, S. (2021) · Bioscience Reports · doi:10.1042/bsr20204113 · Cited by 10
Turan, B., Bengı, G., Çehreli, R., Akpınar, H., & Soytürk, M. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i25.7417 · Cited by 11
Tlaskalová-Hogenová, H., Kverka, M., Verdu, E. F., & Wells, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00008-2 · Cited by 10
Neurophysiologic Mechanisms of Human Large Intestinal Motility
Bharucha, A. E., & Brookes, S. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00036-1 · Cited by 10
Silva, K. F. E., Nanini, H. F., Cascabulho, C. M., Rosas, S. L. B., Santana, P. T., Carneiro, A. J., Anaissie, E. J., Nucci, M., & de Souza, H. S. P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i9.866 · Cited by 9
Metadata
- Authors
- Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A.
- Affiliations
- University of Helsinki (FI)
- Corresponding author
- Palva, Airi
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 133
- Issue
- 1
- Pages
- 24-33
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2024601462
- Cited by
- 1,002
- References
- 53
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 44 · 2023: 40 · 2022: 46 · 2021: 47 · 2020: 40 · 2019: 61 · 2018: 57 · 2017: 55 · 2016: 67 · 2015: 63 · 2014: 83 · 2013: 66 · 2012: 78
- FWCI
- 22.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, fecal microbiota, gut microbiota, 16S rRNA gene sequencing, bacterial population structure, Coprococcus, Collinsella, Coprobacillus, IBS subtypes, bacterial phylotypes
- MeSH terms
- Adult, Aged, Bacteria, Base Composition, Bayes Theorem, Cloning, Molecular, DNA, Bacterial, Feces, Female, Humans, Male, Middle Aged, Phylogeny, RNA, Ribosomal, 16S, Gene Library, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
